IFALD in children: What's new? A narrative review
暂无分享,去创建一个
[1] M. Pakarinen,et al. Histopathological liver steatosis linked with high parenteral glucose and amino acid supply in infants with short bowel syndrome , 2022, JPEN. Journal of parenteral and enteral nutrition.
[2] A. V. Signorini,et al. Outcomes of the First 54 Pediatric Patients on Long-Term Home Parenteral Nutrition from a Single Brazilian Center , 2022, Journal of pediatric gastroenterology and nutrition.
[3] W. Cai,et al. Intestinal Continuity Alleviates Pediatric Intestinal Failure-Associated Liver Disease , 2022, Frontiers in Surgery.
[4] L. D’Antiga,et al. Teduglutide in pediatric intestinal failure: A position statement of the Italian society of pediatric gastroenterology, hepatology and nutrition (SIGENP). , 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[5] E. Ghigo,et al. Efficacy of Teduglutide for Parenteral Support Reduction in Patients with Short Bowel Syndrome: A Systematic Review and Meta-Analysis , 2022, Nutrients.
[6] F. Suchy,et al. Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition–associated cholestasis in mice , 2021, Hepatology.
[7] P. Wales,et al. ASPEN definitions in pediatric intestinal failure. , 2021, JPEN. Journal of parenteral and enteral nutrition.
[8] J. Moon,et al. Evaluation of the fibrosis-4 index for detection of advanced fibrosis among individuals at risk for intestinal failure associated liver disease. , 2021, JPEN. Journal of parenteral and enteral nutrition.
[9] M. Puder,et al. Free Fatty Acid Receptors as Mediators and Therapeutic Targets in Liver Disease , 2021, Frontiers in Physiology.
[10] P. Mohan,et al. Twelve year outcomes of intestinal failure associated liver disease in children with short bowel syndrome: 97% transplant-free survival and 81% enteral autonomy. , 2021, JPEN. Journal of parenteral and enteral nutrition.
[11] D. Christodoulou,et al. New insights into intestinal failure–associated liver disease in adults: A comprehensive review of the literature , 2021, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.
[12] S. Ieiri,et al. The administration of hepatocyte growth factor prevents total parenteral nutrition-induced hepatocellular injury in a rat model , 2021, Pediatric Surgery International.
[13] Justin K Chen,et al. Liver Function in Pediatric Recipients: A Comparison of Intralipid and Smoflipid. , 2021, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.
[14] M. Pakarinen,et al. Prediction, identification and progression of histopathological liver disease activity in children with intestinal failure. , 2020, Journal of hepatology.
[15] Hongyue Wang,et al. Soybean Oil Lipid Minimization for Prevention of Intestinal Failure Associated Liver Disease in Late Preterm and Term Infants with Gastro-Intestinal Surgical Disorders. , 2020, JPEN. Journal of parenteral and enteral nutrition.
[16] F. Mosca,et al. Thrombin Generation in Preterm Newborns With Intestinal Failure-Associated Liver Disease , 2020, Frontiers in Pediatrics.
[17] L. D’Antiga,et al. To Wean or Not to Wean: The Role of Autologous Reconstructive Surgery in the Natural History of Pediatric Short Bowel Syndrome on Behalf of Italian Society for Gastroenterology, Hepatology and Nutrition (SIGENP) , 2020, Nutrients.
[18] Stuart A. Taylor,et al. Serum Scoring and Quantitative Magnetic Resonance Imaging in Intestinal Failure-Associated Liver Disease: A Feasibility Study , 2020, Nutrients.
[19] M. Benninga,et al. The prevalence of liver fibrosis according to non-invasive tools in a pediatric home parenteral nutrition cohort. , 2020, Clinical nutrition.
[20] P. Wales,et al. Composite lipid emulsion for the infant at risk of intestinal failure associated liver disease: the Canadian perspective. , 2020, Journal of pediatric gastroenterology and nutrition.
[21] Francine D Breckler,et al. Pediatric Smoflipid Therapy: Patient Response and Safety Concerns. , 2020, JPEN. Journal of parenteral and enteral nutrition.
[22] R. Sokol,et al. Intestinal failure-associated liver disease (IFALD): insights into pathogenesis and advances in management , 2020, Hepatology International.
[23] F. Tacke,et al. Assessing Non-Invasive Liver Function in Patients with Intestinal Failure Receiving Total Parenteral Nutrition—Results from the Prospective PNLiver Trial , 2020, Nutrients.
[24] C. Gillette,et al. Mixed Oil-Based Lipid Emulsions vs Soybean Oil-Based Lipid Emulsions on Incidence and Severity of Intestinal Failure-Associated Liver Disease in a Neonatal Intensive Care Unit. , 2020, JPEN. Journal of parenteral and enteral nutrition.
[25] W. Cai,et al. Lipid Emulsion Use in Pediatric Patients Requiring Long-Term Parenteral Nutrition. , 2020, JPEN. Journal of parenteral and enteral nutrition.
[26] R. Sokol,et al. New Insights Into Intestinal Failure–Associated Liver Disease in Children , 2020, Hepatology.
[27] M. Beylot,et al. Effect of bile acid supplementation on endogenous lipid synthesis in patients with short bowel syndrome: A pilot study. , 2020, Clinical nutrition.
[28] B. Naini,et al. Something old, something new: liver injury associated with Total parenteral nutrition therapy and immune checkpoint inhibitors. , 2020, Human pathology.
[29] D. Shores,et al. Postoperative Feeding Guidelines Improve Outcomes in Surgical Infants. , 2019, JPEN. Journal of parenteral and enteral nutrition.
[30] P. Mitchell,et al. Growth in Infants and Children with Intestinal Failure Associated-Liver Disease Treated with Intravenous Fish Oil. , 2019, Journal of pediatric gastroenterology and nutrition.
[31] A. Forbes,et al. Home parenteral nutrition with an omega-3-fatty-acid-enriched MCT/LCT lipid emulsion in patients with chronic intestinal failure (the HOME study): study protocol for a randomized, controlled, multicenter, international clinical trial , 2019, Trials.
[32] M. Pakarinen,et al. Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24‐Week, Phase III Study , 2019, JPEN. Journal of parenteral and enteral nutrition.
[33] P. Mitchell,et al. Trends of INR and Fecal Excretion of Vitamin K During Cholestasis Reversal: Implications in the Treatment of Neonates With Intestinal Failure-Associated Liver Disease. , 2019, JPEN. Journal of parenteral and enteral nutrition.
[34] M. Friedrich-Rust,et al. Intestinal failure-associated liver disease in patients with short bowel syndrome: Evaluation by transient elastography. , 2019, Nutrition.
[35] C. Sergi,et al. Mixed Lipid, Fish Oil, and Soybean Oil Parenteral Lipids Impact Cholestasis, Hepatic Phytosterol, and Lipid Composition , 2019, Journal of Pediatric Gastroenterology and Nutrition - JPGN.
[36] Jennifer N. Cooper,et al. Ultrasound Elastography as a Non-Invasive Method to Monitor Liver Disease in Children with Short Bowel Syndrome: Updated Results. , 2019, Journal of pediatric surgery.
[37] Sam M. Han,et al. Noninvasive assessment of liver fibrosis in pediatric intestinal failure patients using liver stiffness measurement by Vibration-Controlled Transient Elastography. , 2019, Journal of pediatric surgery.
[38] J. Bines,et al. Outcomes of Children with Chronic Intestinal Failure: Experience Over Two Decades at a Tertiary Paediatric Hospital. , 2019, Journal of pediatric gastroenterology and nutrition.
[39] V. Kapoor,et al. Lipid emulsions for parenterally fed term and late preterm infants. , 2018, The Cochrane database of systematic reviews.
[40] V. Kapoor,et al. Lipid emulsions for parenterally fed preterm infants. , 2018, The Cochrane database of systematic reviews.
[41] O. Goulet,et al. Long term outcomes of intestinal rehabilitation in children with neonatal very short bowel syndrome: Parenteral nutrition or intestinal transplantation. , 2018, Clinical nutrition.
[42] H. Gwak,et al. Effects of cyclic parenteral nutrition on parenteral nutrition-associated cholestasis in newborns. , 2019, Asia Pacific journal of clinical nutrition.
[43] N. Fidler Mis,et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Lipids. , 2018, Clinical nutrition.
[44] A. Van Gossum,et al. Clinical approach to the management of Intestinal Failure Associated Liver Disease (IFALD) in adults: A position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN. , 2018, Clinical nutrition.
[45] T. Ueno,et al. Three-Year Prospective Follow-up of Potential Pediatric Candidate for Intestinal Transplantation. , 2018, Transplantation proceedings.
[46] L. D’Antiga,et al. Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children , 2018, Nutrients.
[47] Robert H. Squires,et al. The extent of intestinal failure-associated liver disease in patients referred for intestinal rehabilitation is associated with increased mortality: an analysis of the Pediatric Intestinal Failure Consortium database. , 2017, Journal of pediatric surgery.
[48] R. Steiner,et al. Intravenous Fish Oil and Pediatric Intestinal Failure–Associated Liver Disease: Changes in Plasma Phytosterols, Cytokines, and Bile Acids and Erythrocyte Fatty Acids , 2017, JPEN. Journal of parenteral and enteral nutrition.
[49] P. Mitchell,et al. Characterization of Fatty Acid Profiles in Infants With Intestinal Failure–Associated Liver Disease , 2018, JPEN. Journal of parenteral and enteral nutrition.
[50] G. Gondolesi,et al. Utility of Aminotransferase/Platelet Ratio Index to Predict Liver Fibrosis in Intestinal Failure–Associated Liver Disease in Pediatric Patients , 2017, JPEN. Journal of parenteral and enteral nutrition.
[51] B. Feldman,et al. Preventing the Progression of Intestinal Failure–Associated Liver Disease in Infants Using a Composite Lipid Emulsion: A Pilot Randomized Controlled Trial of SMOFlipid , 2017, JPEN. Journal of parenteral and enteral nutrition.
[52] O. Goulet,et al. Intravenous lipid emulsions in pediatric patients with intestinal failure , 2017, Current opinion in organ transplantation.
[53] Takashige Ishikawa,et al. A COMPREHENSIVE REVIEW OF THE LITERATURE ON SHEAR STRENGTH OF PUSH-OUT TESTS OF HEADED STUDS: Comprehensive and holistic analysis focusing on the type of slab, failure mode, and stud diameter , 2017 .
[54] W. Cai,et al. Altered systemic bile acid homeostasis contributes to liver disease in pediatric patients with intestinal failure , 2016, Scientific Reports.
[55] P. Mitchell,et al. Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children. , 2016, The American journal of clinical nutrition.
[56] C. Poisson,et al. Outcome of home parenteral nutrition in 251 children over a 14-y period: report of a single center. , 2016, The American journal of clinical nutrition.
[57] C. Mølgaard,et al. ESPGHAN Committee on Nutrition Position Paper. Intravenous Lipid Emulsions and Risk of Hepatotoxicity in Infants and Children: a Systematic Review and Meta-analysis , 2016, Journal of pediatric gastroenterology and nutrition.
[58] P. Vajro,et al. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment. , 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[59] R. Kivisaari,et al. Transient elastography and aspartate aminotransferase to platelet ratio predict liver injury in paediatric intestinal failure , 2016, Liver international : official journal of the International Association for the Study of the Liver.
[60] C. Sergi,et al. Glucagon-Like Peptide 2 Improves Cholestasis in Parenteral Nutrition--Associated Liver Disease. , 2016, JPEN. Journal of parenteral and enteral nutrition.
[61] K. McHugh,et al. Prevalence of Gallstones Compared in Children With Different Intravenous Lipids , 2015, Journal of pediatric gastroenterology and nutrition.
[62] P. Heikkilä,et al. Loss of ileum decreases serum fibroblast growth factor 19 in relation to liver inflammation and fibrosis in pediatric onset intestinal failure. , 2015, Journal of hepatology.
[63] Y. Révillon,et al. Assessment and outcome of children with intestinal failure referred for intestinal transplantation. , 2015, Clinical nutrition.
[64] L. D’Antiga,et al. Intestinal Failure–Associated Liver Disease: A Position Paper of the ESPGHAN Working Group of Intestinal Failure and Intestinal Transplantation , 2015, Journal of pediatric gastroenterology and nutrition.
[65] K. Iyer,et al. Intestinal Transplant Registry Report: Global Activity and Trends , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[66] D. Seehofer,et al. Reliable assessment of liver function using LiMAx. , 2015, The Journal of surgical research.
[67] P. Heikkilä,et al. Serum plant sterols, cholestanol, and cholesterol precursors associate with histological liver injury in pediatric onset intestinal failure. , 2014, The American journal of clinical nutrition.
[68] A. Diamanti,et al. Long-Term Outcome of Home Parenteral Nutrition in Patients With Ultra-Short Bowel Syndrome , 2014, Journal of pediatric gastroenterology and nutrition.
[69] S. Eaton,et al. Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review. , 2014, JPEN. Journal of parenteral and enteral nutrition.
[70] A. Perez-Atayde,et al. Aspartate Aminotransferase to Platelet Ratio Index Correlates With Hepatic Cirrhosis but Not With Fibrosis in Pediatric Patients With Intestinal Failure , 2013, Journal of pediatric gastroenterology and nutrition.
[71] P. Heikkilä,et al. Persistent abnormal liver fibrosis after weaning off parenteral nutrition in pediatric intestinal failure , 2013, Hepatology.
[72] J. Botha,et al. Hepatic Fibrosis Persists and Progresses Despite Biochemical Improvement in Children Treated With Intravenous Fish Oil Emulsion , 2013, Journal of pediatric gastroenterology and nutrition.
[73] B. Naini,et al. Total parenteral nutrition therapy and liver injury: a histopathologic study with clinical correlation. , 2012, Human pathology.
[74] P. Narula,et al. Hepatocellular carcinoma in a child with intestinal failure-associated liver disease. , 2012, Journal of pediatric gastroenterology and nutrition.
[75] K. Sharif,et al. Long-term Outcomes of Isolated Liver Transplantation for Short Bowel Syndrome and Intestinal Failure–associated Liver Disease , 2012, Journal of pediatric gastroenterology and nutrition.
[76] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[77] D. Zurakowski,et al. Relationship between biopsy-proven parenteralnutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome. , 2010, Journal of pediatric surgery.
[78] Hau D. Le,et al. Parenteral Fish Oil Improves Outcomes in Patients With Parenteral Nutrition-Associated Liver Injury , 2009, Annals of surgery.
[79] P. Vajro,et al. Isolated liver transplantation in children with intestinal failure-associated liver disease: a still-debated matter. , 2009, Journal of pediatric gastroenterology and nutrition.
[80] M. Castro,et al. Prevalence of life-threatening complications in pediatric patients affected by intestinal failure. , 2007, Transplantation proceedings.
[81] S. Kocoshis,et al. Nutritional management of infants with short bowel syndrome. , 2007, Seminars in perinatology.
[82] P. Tsao,et al. Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis. , 2004, The Journal of pediatrics.
[83] R. Ehrenkranz,et al. Total Parenteral Nutrition induced Liver Pathology: An Autopsy Series of 24 Newborn Cases , 2004, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[84] M. Fairchok,et al. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. , 2004, Journal of pediatric gastroenterology and nutrition.
[85] O. Goulet,et al. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. , 2000, JPEN. Journal of parenteral and enteral nutrition.
[86] R. Shamir,et al. Parenteral Nutrition-Associated Cholestasis in Preterm Neonates: Evaluation of Ursodeoxycholic Acid Treatment , 1999, Journal of pediatric endocrinology & metabolism : JPEM.
[87] A. Guarino,et al. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. , 1996, Gastroenterology.
[88] P. Ingrand,et al. Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease? , 1994, Journal of hepatology.
[89] K. Ishak,et al. Total parenteral nutrition: a histopathologic analysis of the liver changes in 20 children. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.